Clinical features of gastrointestinal symptoms in women with recurrent course of deep infiltrative endometriosis

Background. Endometriosis is a chronic multifactorial disease that affects more than 170 million women of reproductive age worldwide, causing pelvic pain syndrome, dyspareunia, and symptoms of gastrointestinal dyspepsia, thereby having a negative impact on the psycho-emotional state of patients. Despite a wide range of medical and surgical treatments, the relapse rate reaches 50%, which is a global economic and social problem.

The purpose of the study. To determine the spectrum of clinical features of the gastrointestinal tract in women with recurrent deep infiltrative endometriosis.

Materials and methods. The study included 113 patients of reproductive age who underwent surgical treatment of common forms of external genital endometriosis. The main group consisted of 32 patients who underwent repeated surgical treatment due to relapse of deep infiltrative endometriosis, the comparison group — 51 patients without relapse of the disease one year after the primary operation, the control group — 30 patients of reproductive age who did not suffer from external genital endometriosis. An analysis of the somatic anamnesis was carried out, as well as questionnaire data on pelvic pain on a visual analogue scale (VAS) and functional bowel disorders in patients with deep infiltrating endometriosis, depending on the status of relapse of the disease.

Results and discussion. Patients of the main group suffered significantly more often from functional diseases of the gastrointestinal tract (71.9% (23/32) versus 51.3% (26/51) in the comparison group; p = 0.006, the spectrum of which was represented by chronic gastritis and irritable bowel syndrome. In the main group, the clinical manifestations of gastrointestinal dyspepsia before surgical treatment correspond to a moderately severe degree of 17.706 (4.601) points. A significantly higher initial level of functional intestinal disorders was established during subjective assessment in the main observation group: 17.706 (4.601) points versus 10.66 (3.61) points in the comparison group; p=0.001. In women of the main observation group, one month after surgical treatment, there was a significant decrease in subjective assessment of the severity of functional intestinal disorders (from 17.71 (4.60) points to 9.86 (4.73) points; p = 0.001). The integral VAS pain score in the main group was 6.65 (1.53) points, which is significantly higher than in patients in the comparison group without relapse of the disease.

Conclusions. The identified clinical and anamnestic predictors of the recurrent course of deep infiltrative endometriosis will allow us to formulate a personalized approach at the pre- and postoperative stage, aimed at preventing relapse of the disease, which will directly improve the psycho-emotional state and quality of life of women.

1. Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, Kohlmeier A, Yin P, Milad M, Wei J. Endometriosis. Endocr Rev. 2019. 1;40(4):1048-1079. https://doi:10.1210/er.2018-00242

2. Sarria-Santamera A. et al. Systematic review and meta-analysis of incidence and prevalence of endometriosis. Healthcare. MDPI, 2020; 9 (1):29. https://doi:10.3390/healthcare9010029

3. Levy AR, Osenenko KM, Lozano-Ortega G, Sambrook R, Jeddi M, Bélisle S, Reid RL. Economic burden of surgically confirmed endometriosis in Canada. Journal of Obstetrics and Gynaecology Canada. 2011; 33(8):830-837. https://doi.org/10.1016/S1701-2163(16)34986-6

4. Berlanda N., Vercellini P., Fedele L. The outcomes of repeat surgery for recurrent symptomatic endometriosis. Current Opinion in Obstetrics and Gynecology.2010;22(4):320-325. https://doi.org/10.1097/gco.0b013e32833bea15

5. Chernukha G. E., Ilyina L. M., Adamyan L. V., Pavlovich S.V. Deep infiltrative endometriosis: postoperative relapses and possible ways to prevent them. Obstetrics and Gynecology. 2015;8:39-46. (In Russ.)

6. Taylor H. S., Kotlyar A. M., Flores V. A. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations.The Lancet. 2021;397(10276):839-852. https://doi:10.1016/S0140-6736(21)00389-5

7. Peters M, Mikeltadze I, Karro H, Saare M; Estonian Biobank Research Team; Salumets A, Mägi R, Laisk T. Endometriosis and irritable bowel syndrome: similarities and differences in the spectrum of comorbidities. Human Reproduction.2022;37(9): 2186-2196. https://doi:10.1093/humrep/deac140

8. Chiaffarino F, Cipriani S, Ricci E, Mauri PA, Esposito G, Barretta M, Vercellini P, Parazzini F. Endometriosis and irritable bowel syndrome: a systematic review and meta-analysis.Archives of gynecology and obstetrics. 2021; 303:17-25. https://doi.org/10.1007/s00404-020-05797-8

9. Ford AC, Sperber AD, Corsetti M, Camilleri M. Functional gastrointestinal disorders 2 irritable bowel syndrome. Lancet. 2020; 396(10263):1675-1688. https://doi.org/10.1016/S0140-6736(20)31548-8

10. Moore JS, Gibson PR, Perry RE, Burgell RE. Endometriosis in patients with irritable bowel syndrome: specific symptomatic and demographic profile, and response to the low FODMAP diet. Australian and New Zealand Journal of Obstetrics and Gynaecology.2017;57(2):201-205. https://doi.org/10.1097/01.ogx.0000521120.13781.58

11. Ivashkin V.T., Sheptulin A.A., Poluektova E.A., Reichart D.V., Belostotsky A.V., Drozdova A.A., Arnautov V.S. Possibilities of using the “7x7” Questionnaire (7 symptoms in 7 days) to assess the dynamics of symptoms of functional dyspepsia and irritable bowel syndrome. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016; 26(3):24-33. (In Russ.) https://doi.org/10.22416/1382-4376-2016-26-3-24-33

12. Yang F, Wu Y, Hockey R; International Endometriosis Genetics Consortium; Doust J, Mishra GD, Montgomery GW, Mortlock S. Evidence of shared genetic factors in the etiology of gastrointestinal disorders and endometriosis and clinical implications for disease management. Cell Reports Medicine.2023;4:11. https://doi.org/10.1016/j.xcrm.2023.101250

13. Zhu Y, Li Y, Zhang Q, Song Y, Wang L, Zhu Z. Interactions between intestinal microbiota and neural mitochondria: A new perspective on communicating pathway from gut to brain. Frontiers in Microbiology. 2022;13:798917. https://doi.org/10.3389/fmicb.2022.798917

14. Johnson NP, Hummelshoj L, Adamson GD, Keckstein J, Taylor HS, Abrao MS, Bush D, Kiesel L, Tamimi R, Sharpe-Timms KL, Rombauts L, Giudice LC. World Endometriosis Society consensus on the classification of endometriosis. Human reproduction. 2017; 32(2): 315-324. https://doi.org/10.1093/humrep/dew293